Givlaari®

Active substance

givosiran

Holder

Alnylam Netherlands B.V.

Status

Closed

Indication

treatment of acute hepatic porphyria (AHP) in adults and adolescents (≥12 years of age).

Public documents

Approbation

Approbation amendment

Approbation amendment 2

Information  for the patient

Informed consent 

Last update

28/06/2021